1 / 5

Rucaparib tablets and dosage manual

Rucaparib is a PARP inhibitor(a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase) used as an anti-cancer agent.

shipra2
Download Presentation

Rucaparib tablets and dosage manual

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Rucaparib: tablets and dosage manual Rucaparib is a PARP inhibitor(a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase) used as an anti-cancer agent. Rucaparib camsylate is a white- pale yellow powder formulated into a tablet and is taken orally. Rucaparib tablets standard strength is 300 mg. Rucaparib is used to treat ovarian cancer and prostate cancer.

  2. Dosage and administration The inactive ingredients of Rucaparib are microcrystalline cellulose, sodium starch glycolate, colloidal silicon dioxide, and magnesium stearate. Before administering the Rucaparib tablets, the patients should consult the health care professional for proper dosage according to the patient's medical history. The General recommended dose of Rubraca is 600 mg (two 300 mg tablets) taken twice a day orally with or without food, a total daily dose of 1,200 mg.

  3. Side Effects of Rucaparib There are numerous side effects of the medicine Rucaparib. Common side effects are tiredness or weakness, nausea, vomiting, decreased hunger, dysgeusia, diarrhea, thrombocytopenia (low levels of platelets), and abdominal pain. Severe side effects are increased levels of creatinine (which may indicate kidney problems), liver enzymes in the blood (indication of liver problems), blood in urine, anemia (low red blood cell counts).

  4. Precautions Before administering, the patient should acknowledge the doctor about allergies or allergic reactions asRucaparib 300 mg contains several inactive ingredients which may be allergic to the patient. Clinical advice is that females and males of reproductive potential should avoid becoming pregnant or planning to become pregnant while treating with Rucaparib because this medicine has potential risk to the fetus. Reproductive females and males should use effective contraception during treatment and 6 months after the last dose of the drug.

  5. Availability in India The Indian Pharma (TIP) helps connect buyers with suppliers who can ship RUBRACA at the global level as per the need of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the RUBRACA Tablets.

More Related